COMMUNIQUÉS West-GlobeNewswire

Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer

27/01/2025 - 14:00

Experienced financial leader joins as the company prepares for its public market entry NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc., (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech [...]

Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer

27/01/2025 - 14:00

BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the [...]

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

27/01/2025 - 14:00

BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

27/01/2025 - 14:01

BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]

Umoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical Officer

27/01/2025 - 14:05

SEATTLE, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced the [...]

Novo Nordisk A/S - share repurchase programme

27/01/2025 - 14:05

Bagsværd, Denmark, 27 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT

27/01/2025 - 14:30

Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated donors Encouraging pilot study results demonstrated the benefit of vaccinating [...]

KFSHRC Heart Centre: A Leader in Advanced Cardiac Treatments

27/01/2025 - 14:30

Revolutionizing care from minimally invasive surgery to comprehensive outpatient services RIYADH, Saudi Arabia, Jan. 27, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has [...]

FDA Authorizes Myocene Device for Muscle Fatigue Monitoring and Informed Training Decisions

27/01/2025 - 15:00

LIÈGE, Belgium, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech company specializing in innovative muscle fatigue assessment for top-level athletes announced today that the US Food and Drug [...]

Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day

27/01/2025 - 15:00

- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT ® - - Ad-hoc analyses of pancreatic cancer population subgroups [...]

Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education

27/01/2025 - 15:00

Latest donation brings total contribution to more than $170 million SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of [...]

Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance

27/01/2025 - 15:00

New unified model developed by UsAgainstAlzheimer's, the Davos Alzheimer's Collaborative and the McKinsey Health Institute provides roadmap for employers to promote employee brain health for better business outcomes [...]

BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions

27/01/2025 - 15:15

SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA] today announced that the results of its double-blind randomized placebo-controlled CardiAMP HF Phase 3 study have been accepted for [...]

PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor

27/01/2025 - 15:29

PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading [...]

ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders’ Meeting

27/01/2025 - 15:31

Aimed at enhancing U.S. outreach, investor relations, corporate dialogue, and business development (BD) capabilities MADRID and CAMBRIDGE, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: [...]

With significant clinical results published in the Nature Medicine Journal, InBrain Pharma is about to durably modify the advanced Parkinson's disease management

27/01/2025 - 16:00

A World Premiere in Parkinson’s Disease With significant clinical results published in the Nature Medicine Journal, InBrain Pharma is about to durably modify the advanced Parkinson's disease management A breakthrough [...]

Plantsulin: Introducing Plantsulin –Ingredients, Study Findings and Where to Buy

27/01/2025 - 16:31

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Plantsulin is more than just another blood sugar supplement—it’s a science-backed breakthrough poised to tackle the deeply rooted metabolic challenges underlying Type 2 [...]

Comprehensive Healthcare Pledges $300,000 to Support the MLK Jr. Aquatic Center Project

27/01/2025 - 17:40

YAKIMA, Wash., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is proud to announce a $300,000 donation to the Yakima Valley Community Foundation’s Martin Luther King Jr. Swimming Pool project. This generous [...]

MedX Holdings, Inc. (OTC: MEDH) Achieves PINK Current Status, Celebrates 20 Years of Lazydaze, Launches AI-Powered Vending, and Announces Bold Expansion Plans

27/01/2025 - 18:10

Austin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- [Austin, Texas – [1/27/2025] – MedX Holdings, Inc. (OTC: MEDH), a trailblazer in the cannabis and cannabis-adjacent industries, is thrilled to announce its return to active [...]